US tells J&J millions of vaccine doses from troubled plant can’t be used

Agence France-Presse

The US Food and Drug Administration said Friday it had told Johnson & Johnson that millions of doses of Covid vaccine produced at a troubled plant can’t be used because of possible contamination issues.

The US Food and Drug Administration said Friday it had told Johnson & Johnson that millions of doses of Covid vaccine produced at a troubled plant can’t be used because of possible contamination issues.

In a statement, the FDA said “several” batches of vaccine manufactured at the Emergent BioSolutions facility in the city of Baltimore are not suitable for use. Each batch is known to correspond to several million doses.

Neither the agency nor J&J revealed the precise number of doses, but The New York Times placed the number at 60 million, quoting people familiar with the matter.

“These actions followed an extensive review of records, including the production history of the facility and the testing performed to evaluate the quality of the product,” said FDA scientist Peter Marks.

Read more of this story

(Visited 1 times, 1 visits today)
About Cholo Brooks 14980 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.

Be the first to comment

Leave a Reply

Your email address will not be published.


*